Joseph Albright, DPM
Primary Podiatric Medicine · Watsonville, CANPI 1568991073
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,651 of the $2,290 with a category attached, or 72.1%. 11 manufacturers reported payments, led by Orthofix Medical, Inc. at 32.6% of the total. Reporting peaked in 2021 at $1,244 and has fallen 75.0% since, to $311 in 2025.
Across 40 payments — averaging $57.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$747
- Smith+Nephew$447
- Stryker$442
- Johnson & Johnson$241
- Alafair Biosciences, Inc.$177
- Tactile Systems Technology Inc$92
- plus $143 from 5 others
What the payments were for
- Travel & lodging$63928%
- Food & beverage$1,65172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 10 | $747 |
| Smith+Nephew | 8 | $447 |
| Stryker | 7 | $442 |
| Johnson & Johnson | 6 | $241 |
| Alafair Biosciences, Inc. | 2 | $177 |
| Tactile Systems Technology Inc | 1 | $92 |
| Integra Lifesciences Corporation | 2 | $57 |
| Paragon 28, Inc. | 1 | $27 |
| Urgo Medical North America, LLC | 1 | $25 |
| Convatec Inc. | 1 | $19 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,290 in reported general payments places this provider in the 70th percentile of 59 primary podiatric medicine providers in California.
See all primary podiatric medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 27 | $1,047 |
| Ketoconazole | 29 | $577 |
| Doxycycline Hyclate | 48 | $423 |
| Terbinafine Hcl | 36 | $224 |
| Mupirocin | 41 | $214 |
| Methylprednisolone | 33 | $211 |
| Cephalexin | 51 | $178 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $151 |
| Meloxicam | 93 | $143 |
| Triamcinolone Acetonide | 19 | $80 |
| Naproxen | 28 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Watsonville
- Nicole SurdockWatsonville$187
- James WangLos Angeles$250K
- Adam ShapiroUpland$21K
- Ali GhorbanifarajzadehBakersfield$17K
- Abid ChaudhryArleta$11K
- Matthew GarrisonSacramento$7K
- Linh HuynhTurlock$7K
- Yvette CanabaSantee$5K
- David KhakshoorLos Angeles$4K
- Katrina SergeevaVista$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.